Directed evolution of a recombinase for improved genomic integration at a native human sequence

Area of Science:

• Molecular Biology
• Genomics
• Biotechnology

Background:

• Site-specific recombinases, like phage phiC31 integrase, facilitate DNA integration into host genomes.
• Phage phiC31 integrase targets specific attB and pseudo attP sites for unidirectional integration.
• Existing integrases have limitations in frequency and specificity for mammalian genome modification.

Purpose of the Study:

• To evolve phage phiC31 integrase variants with enhanced integration efficiency and specificity.
• To develop custom DNA integration tools for precise genome engineering in human cells.

Main Methods:

• Utilized DNA shuffling and screening in Escherichia coli to generate and select improved integrase variants.
• Assessed integration frequency and specificity of evolved integrases at a pseudo attP site on human chromosome 8.
• Validated enzyme performance within the native genomic environment of living human cells.

Main Results:

• Identified evolved integrases with significantly enhanced integration frequency compared to the wild-type enzyme.
• Demonstrated improved sequence specificity of the engineered integrases at the target pseudo attP site.
• Confirmed the utility of these custom integrases for genome modification in a human cellular context.

Conclusions:

• Engineered phage phiC31 integrases offer superior performance for site-specific DNA integration in mammalian genomes.
• These enhanced integrases represent valuable tools for advancing genome engineering applications in higher eukaryotes.
• Custom recombinase development through directed evolution is a viable strategy for improving biotechnological tools.